Sign in
4

Changes in Ownership

TherapeuticsMD, Inc. Filed Acc 0001209191-23-005554

Prin. Fin. and Acctg. Officer sold 1,697 shares at an average $5.08 ($8,621)

  • Prin. Fin. and Acctg. Officer acquired 5,940 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Donegan Michael C · Prin. Fin. and Acctg. Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2023-01-26 Exercise or conversion : show line 1 in the form +2,400 10,010 D
2023-01-26 Exercise or conversion : show line 2 in the form +2,400 12,410 D
2023-01-26 Exercise or conversion : show line 3 in the form +1,140 13,550 D
2023-01-26 Sale : show line 4 in the form −1,648 $5.08 $8,371 11,902 D
2023-01-27 Sale : show line 5 in the form −49 $5.09 $249 11,853 D
Open-market sales · 1,697 sh · avg $5.08 · $8,621

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2023-01-26 Exercise or conversion : show line 6 in the form Performance Stock Units −2,400 0 D
2023-01-26 Exercise or conversion : show line 7 in the form Performance Stock Units −2,400 0 D
2023-01-26 Exercise or conversion : show line 8 in the form Performance Stock Units −1,140 0 D
Loading xslF345X03/doc4.xml…